MILANESE, Giulio
 Distribuzione geografica
Continente #
NA - Nord America 8.562
EU - Europa 7.071
AS - Asia 3.966
SA - Sud America 896
AF - Africa 262
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 7
Totale 20.778
Nazione #
US - Stati Uniti d'America 8.393
IT - Italia 2.771
RU - Federazione Russa 1.365
SG - Singapore 1.293
VN - Vietnam 815
CN - Cina 720
BR - Brasile 706
UA - Ucraina 601
DE - Germania 438
HK - Hong Kong 387
IE - Irlanda 355
FR - Francia 319
SE - Svezia 319
TR - Turchia 218
FI - Finlandia 215
DK - Danimarca 200
GB - Regno Unito 170
CI - Costa d'Avorio 130
KR - Corea 120
NL - Olanda 115
IN - India 90
CA - Canada 77
AR - Argentina 67
MX - Messico 66
BD - Bangladesh 60
JP - Giappone 40
PL - Polonia 40
ZA - Sudafrica 37
IQ - Iraq 35
ES - Italia 33
EC - Ecuador 30
BE - Belgio 26
MA - Marocco 26
CO - Colombia 24
ID - Indonesia 23
PK - Pakistan 22
VE - Venezuela 21
CL - Cile 20
UZ - Uzbekistan 20
AT - Austria 19
PH - Filippine 19
LT - Lituania 15
LY - Libia 15
DZ - Algeria 14
EU - Europa 11
IL - Israele 11
AE - Emirati Arabi Uniti 10
SA - Arabia Saudita 10
TN - Tunisia 10
JO - Giordania 9
PE - Perù 9
CH - Svizzera 8
PY - Paraguay 8
AL - Albania 7
AU - Australia 7
EG - Egitto 7
MY - Malesia 7
RO - Romania 7
TW - Taiwan 7
UY - Uruguay 7
CR - Costa Rica 6
KE - Kenya 6
AZ - Azerbaigian 5
GR - Grecia 5
MD - Moldavia 5
SI - Slovenia 5
TH - Thailandia 5
BH - Bahrain 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
GE - Georgia 4
HR - Croazia 4
KZ - Kazakistan 4
SN - Senegal 4
BN - Brunei Darussalam 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
IR - Iran 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
CG - Congo 2
EE - Estonia 2
LV - Lettonia 2
MN - Mongolia 2
MT - Malta 2
NG - Nigeria 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
VA - Santa Sede (Città del Vaticano) 2
Totale 20.754
Città #
Dallas 1.769
Ashburn 1.105
Singapore 775
Jacksonville 560
Chandler 522
Hong Kong 368
Dublin 351
Boardman 346
San Jose 343
Fairfield 295
New York 287
Ho Chi Minh City 265
Wilmington 234
Beijing 228
Des Moines 209
Milan 200
Hanoi 183
The Dalles 176
Rome 164
Seattle 153
Lauterbourg 140
Abidjan 130
Ann Arbor 130
Los Angeles 128
Moscow 128
Lawrence 118
Princeton 118
San Mateo 113
Woodbridge 110
Hefei 88
Houston 85
Helsinki 76
Munich 76
São Paulo 64
Cambridge 63
Ancona 62
Naples 60
Council Bluffs 56
Buffalo 52
Chicago 50
Turin 48
Orem 46
Palermo 42
San Diego 39
Turku 39
Centro 38
Haiphong 35
Da Nang 34
London 33
Florence 30
Montreal 30
Bologna 29
Perugia 29
Frederico Westphalen 28
Warsaw 28
Tokyo 27
Bari 26
Brussels 26
Porto 26
Santa Clara 26
Frankfurt am Main 24
Mexico City 24
Rio de Janeiro 24
Pesaro 23
Berlin 22
Chennai 22
Johannesburg 22
Denver 21
Nuremberg 20
Tashkent 20
Rapagnano 19
Salt Lake City 19
Shanghai 19
Toronto 19
Washington 19
Brooklyn 18
Poplar 18
Stockholm 18
Caserta 17
Can Tho 16
Manchester 16
Marche 16
Amsterdam 15
Pune 15
Boston 14
Buenos Aires 14
Catania 14
Curitiba 14
Guangzhou 14
Hải Dương 14
Napoli 14
Phoenix 14
Petritoli 13
Porto Alegre 13
Tripoli 13
Vienna 13
Biên Hòa 12
Brescia 12
Columbus 12
Corridonia 12
Totale 11.717
Nome #
110 SERUM LEVELS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR IN PATIENTS WITH PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA 2.222
Isosorbide dinitrato per la disfunzione erettile 1.234
L’invasione linfovascolare e l’infiltrazione perineurale come fattori prognostici predittivi di recidiva biochimica precoce dopo prostatectomia radicale 869
Analisi della perdita di eterozigosi (LOH) nelle neoplasie della vescica mediante elettroforesi capillare 268
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 185
Clinical progression of megacalycosis in a girl with a solitary kidney: The lesson learned 184
A conservative approach to perineal Fournier's Gangrene 179
Clinical performance and utility of a NNMT-based urine test for bladder cancer 178
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 171
Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy? 169
Neoplasie vescicale pT1G2-3: risultati della nostra esperienza dopo TURV seguita da che mio- o immunoprofilassi e follow-up medio di 4 anni 167
Analisi dell’instabilità dei microsatelliti nelle neoplasie della vescica mediante elettroforesi capillare. esperienza preliminare 166
Normal human macula densa morphology and cell turnover: A histological, ultrastructural, and immunohistochemical investigation 166
Carcinoma prostatico solitario della zona di transizione. 155
Neutrophil‑to‑lymphocyte ratio may be associated with the outcome in patients with prostate cancer 155
464 Cost comparison for different medical treatments in conservative — expulsive therapy of distal ureteral stones 152
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 152
Correlation between urodyanamics and perineal ultrasound in female patients with urinary incontinence. 151
An update of in-vivo application of artificial intelligence and robotics for percutaneous nephrolithotripsy. Results from a systematic review 147
Valutazione della qualità di vita al follow-up dopo cistectomia radicale: derivazioni urinarie a confronto, la nostra esperienza. 147
Evidence for the presence of a1 adrenoreceptor subtypes in the human ureter 147
FUNCTIONAL OUTCOME EVALUATION AFTER REHABILITATION OF PELVIC FLOOR AFTER ROBOTIC RADICAL PROSTATECTOMY (RARP) VERSUS RETROPUBIC RADICAL PROSTATECTOMY (RRP) 145
Dual energy CT combined with infrrede spectroscopy: imaging to predict urinary stones composition and stiffness 143
Association between trauma and cancer of the testis: the importance of self-palpation of the testis for the early detection: two case reports. 141
Do DNA methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up. 140
Angiogenesis as prognostic factor in small renal tumors 140
370Ultrasound evaluation of bladder neck complex alterations in chronic prostatitis/chronic pelvic pain syndrome 139
465 Alpha1 adrenoceptor subtypes in men juxtavesical ureters: Molecular and pharmacological characterization 137
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report 137
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 136
PEC-OME of the prostate: case report 135
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines 134
Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up 134
602 SIMULTANEOUS TURB-TURP IN PATIENTS WITH BLADDER CANCER AND BPH: A PROSPECTIVE RANDOMIZED TRIAL ON RELAPSES OCCURRENCE AND TREATMENT-RELATED QUALITY OF LIFE 132
Primary testicular lymphoblastic B lymphoma: ultrasonographic features and clinical implications 132
Extracorporeal shock wave lithotripsy, ureterolithotripsy, and percutaneous nephrolithotripsy challenges in managing spinal cord neuropathy patients. Lessons learned from a scoping review 131
Biomarkers for VEGF-Targeted Therapy in Renal Cell Carcinoma: Critical Review of Level of Evidence and Up to Date 131
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 129
Randomized trial on the efficacy of tamsulosin, nifedipine and phloroglucinol in medical-expulsive therapy of distal ureteral calculi. 128
Le biopsie mirate su lesioni ipoecogene migliorano la correlazione del grading tra biopsia e prostatectomia radicale. 127
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 126
Unusual clinical scenarios in Urology and Andrology 125
The influence of lead exposure on male semen parameters: A systematic review and meta-analysis 124
Prognostic role of Furhman grade and vascular endothelia growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens 124
Is spinal anesthesia a safe alternative for retrograde intrarenal surgery for stone disease in daily practice? 123
77 Soluble urokinase receptor expression in urine is a prognostic marker in patients with transitional cell carcinoma of the bladder 123
Case report: A hybrid technique for a safe nephrectomy in a giant kidney angiomyolipoma 122
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 120
Novità nel trattamento della calcolosi urinaria 120
I frammenti di biopsia prostatica: caratteristiche, dimensioni e numero 120
Identificazione dell’enzima nicotinamide n-metiltransferasi quale marker molecolare del carcinoma renale a cellule chiare. 120
The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. 120
Concomitant robot-assisted laparoscopic surgeries for upper and lower urinary tract malignancies: a comprehensive literature review 120
Current evidence on surgical management for benign prostatic hyperplasia in renal transplant recipients: a systematic review 120
Impact of ureteral sheath on success and complications after RIRS: does size matter? 118
Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up 117
Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database 117
Safety and efficacy of transurethral resection of prostate gland up to 150 mls: a prospective comparative study with 1 year follow-up 116
Prognostic role of microvessel density (MVD), vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1alfa (HIF-1alfa) in patients with conventional clear cell renal carcinoma after radical nephrectomy in a long term follow-up 116
IMPORTANCE OF LENGTH OF RADIAL EXTRAPROSTATIC EXTENSION IN 101 PATIENTS PT3A R0 LVI0 N0 116
Correlation between ultrasound alterations of the preprostatic sphincter and symptoms in patients with chronic prostatitis-chronic pelvic pain syndrome 114
THE ACCURACY OF (CU)-C-64-PSMA PET/TC IN IDENTIFYING THE SITE OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH LOW PSA VALUES (< 2 ng/ml) 113
PSA-IGM BASED ALGORITHM (IXIP SCORE) DURING FOLLOW-UP OF ACTIVE SURVEILLANCE 113
Iperespressione della 5-lipossigenasi nel carcinoma renale a cellule chiare. 112
Simultaneous Inguinal Hernia Repair with Monofilament Polypropylene Mesh during Robot-Assisted Radical Prostatectomy: Results from a Single Institute Series 111
Conservative management of juxtavesical calculi with tamsulosin 110
Identification of paraoxonase-2 as potential biomarker for bladder cancer 109
Evaluation of urinary Nicotinamide N-methyltransferase: a non-invasive diagnostic test for bladder cancer 108
Catechol-o-methyltransferase, a promising diagnostic marker for non-invasive detection of human urothelial carcinoma 107
Migrazione di stadio in campioni di prostatectomia radicale: analisi di 15 anni. 107
Efficacy and safety of alfa-1-blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a prospective study 105
Does Alexis Wound Protector/Retractor Reduce the Risk of Surgical Site Infections After Open Radical Cystectomy for Bladder Cancer? Results From a Single Center, Comparative Study 103
Increased expression of 5-lipoxygenase is common in clear cell renal carcinoma 103
NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER: DIFFERENCES IN CLINICAL AND PATHOLOGICAL RESPONCE 103
Fragments of prostatic biopsy: characteristics, dimensions, and number. 103
Non dilated obstructive uropathy secondary to tur-syndrome in patient with solitary kidney 102
Ruolo prognostico della metilazione globale e della acetilazione nelle neoplasie renali a cellule chiare pT1a trattate con nefrectomia parziale 102
FOCAL THERAPY OF LOCALIZED PROSTATE CANCER WITH "FUSION" INTEGRATED PATH AND HIGH INTENSITY FOCUSED ULTRASOUND (HIFU): INITIAL EXPERIENCE 102
Robot-assisted segmental ureterectomy with psoas hitch ureteral reimplantation: Oncological, functional and perioperative outcomes of case series of a single centre 102
Nicotinamide N-methyltransferase as potential diagnostic marker in patients with urinary bladder carcinoma: a real-time approach. 101
DIFFERENCES IN CLINICAL AND PATHOLOGICAL RESPONSE TO NEOADIUVANT CHEMOTHERAPY IN PATIENTS WITH INVASIVE BLADDER CANCER 101
PERI-OPERATIVE OUTCOMES OF OPEN VERSUSROBOT-ASSISTED SIMPLE PROSTATECTOMY: RESULTS FROMTWO HIGH-VOLUME CENTRES 100
α1-Blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: A prospective randomized study. 100
INTRADUCTAL CARCINOMA IN LOW- AND INTERMEDIATE-RISK PROSTATE CANCER: PATHOLOGICAL AND CLINICAL RELEVANCE 100
The pathway of isolated seminal vesicle invasion has a different impact on biochemical recurrence after radical prostatectomy and pelvic lymphadenectomy 99
Seminal vesicle invasion in pT3bN0cM0 prostate cancer patients treated with radical prostatetectomy: Impact of Ohori patterns of invasion on biochemical recurrence 99
Quantitative analysis of Nicotinamide N-methyltransferase expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection. 99
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 99
Infezione virale da Herpes virus come possibile causa di ritenzione urinaria. Caso clinico 98
Prognostic role of global DNA-methylation and histone acetylation in pT1a clear cell renal carcinoma in partial nephrectomy specimens 98
Quality of life in the follow-up after radical cystectomy: comparison between different urinary diversions 97
Efficacy of 1-Year Cavacurmin® Therapy in Reducing Prostate Growth in Men Suffering from Lower Urinary Tract Symptoms 97
IMPACT OF INTEGRATED CARE PATHWAY FOR BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS IN MARCHE REGION 96
Loss of nuclear BAP1 protein expression is a marker of poor prognosis in patients with clear cell renal cell carcinoma 96
Does Hounsfield Unit have any significance in predicting intra and postoperative outcomes in retrograde intrarenal surgery using holmium and Thulium fiber laser? A critical analysis of results from the FLEXible ureteroscopy Outcomes Registry (FLEXOR) 96
Diffusione ghiandolare del carcinoma prostatico: schema di rappresentazione stereografica su reperti ecografici e bioptici 95
Ruolo prognostico della metilazione globale e della acetilazione nelle neoplasie renali a cellule chiara pT1a trattate con nefrectomia parziale 94
Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. 93
CORRELATION BETWEEN TUMOUR CHARACTERISTICS AND PERIOPERATIVE OUTCOMES IN NEPHRON SPARING SURGERY 93
Enhanced expression of Nicotinamide N-methyltransferase in human renal clear cell carcinoma. 92
Totale 16.414
Categoria #
all - tutte 79.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021340 0 0 0 0 0 0 0 0 0 102 171 67
2021/2022939 51 221 29 55 18 51 25 88 79 80 48 194
2022/20232.059 159 179 163 140 141 349 22 130 534 42 123 77
2023/20241.887 251 65 97 235 224 349 48 93 29 140 133 223
2024/20253.434 372 272 195 107 200 133 345 189 653 215 353 400
2025/20268.818 554 884 1.477 792 799 563 1.369 678 1.251 451 0 0
Totale 21.068